My insurance denied Wegovy. Are compounded GLP-1s my best option?

Short answer: not usually. Compounded GLP‑1s can seem cheaper, but they carry safety, quality, and legal risks. Before picking a compounded product, try other safer, usually better options.

Steps and options to consider

1. Appeal the denial

• Ask your prescriber to submit a formal prior‑authorization appeal or peer‑to‑peer review. Insurers will reverse denials if you document BMI, weight‑related comorbidities, and past attempts at lifestyle/other therapies. This is often the fastest way to get Wegovy covered.

1. Manufacturer help and savings

• Check Novo Nordisk’s patient assistance/savings programs for Wegovy and ask your clinic to help enroll you. If you’re eligible, that can cut your out‑of‑pocket cost a lot.
• Use price‑comparison tools (GoodRx, SingleCare) to see cash prices for alternatives like Ozempic.

1. FDA‑approved alternatives (safer than compounding)

• Zepbound (tirzepatide) — Eli Lilly: newer, highly effective for weight loss; check Lilly’s savings/assistance programs.
• Ozempic (semaglutide) — Novo Nordisk: approved for diabetes but commonly used off‑label for weight loss; may be cheaper in some cases.
• Saxenda (liraglutide), Qsymia, Contrave, orlistat — available alternatives depending on your medical profile. Ask your prescriber whether one of these is clinically appropriate; insurers sometimes cover a different drug more readily.

1. Telemedicine/weight‑loss clinics

• Services such as One Medical, Ro (Roman), Hims & Hers, or local endocrine/weight‑management clinics can evaluate you, help with appeals, and prescribe alternatives. They can also arrange follow‑up monitoring.

1. If you’re considering compounded GLP‑1s — pros and important cautions

• Pros: sometimes lower cash price; may be available if commercial product is unreachable.
• Major cons: compounded GLP‑1s are not FDA‑approved. Potency, sterility, and purity can vary; there have been reports of labeling and dosing errors with compounded injectables. Insurers and many clinics will not endorse them.
• If you still pursue compounding, use only accredited, reputable compounding pharmacies that provide certificates of analysis and follow sterile compounding standards (USP <797>) and independent lab testing. Examples of national compounding pharmacies you can check (verify current accreditation and testing before ordering): ImprimisRx, Wedgewood Pharmacy, Empower Pharmacy. Ask for PCAB accreditation, sterility test reports, and batch COAs (certificate of analysis).
• Discuss with your prescriber about monitoring, injection technique, and where to get emergency help if you have adverse effects.

Bottom line recommendation

• First: appeal the Wegovy denial and ask about manufacturer assistance.
• Second: discuss switching to another FDA‑approved option (Zepbound, Ozempic, Saxenda, etc.) that your insurer might cover.
• Only consider compounded GLP‑1s if you can’t get any approved option and you’ve confirmed a trustworthy, PCAB‑accredited compounding pharmacy and discussed risks with your clinician.

If you want, tell me whether your insurer denied Wegovy for cost/prior‑auth or for another reason, and whether you have a preferred budget — I can suggest a next specific step (how to structure an appeal letter, which drug to discuss with your clinician, or compounding pharmacies to contact).